Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Phico Therapeutics
Phico Therapeutics
Activities:
Research & Development
Infection Control
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Phico Therapeutics appoints Financial Director and two non-executives
Pharmaceutical
Phico Therapeutics awarded Innovate UK funding
The funding will support development of a <i>Pseudomonas aeruginosa</i> targeted therapeutic, to tackle the genetic cause of antibiotic resistance
Research & Development
Phico Therapeutics receives £2.25m grant to advance its SASPject PT4 towards clinical trials
The antibiotic is aimed at Escherichia coli and Klebsiella pneumoniae
Research & Development
Phico raises further funds to fight E.coli
To develop SASPject antibiotic technology
Research & Development
Phico Therapeutics raises £1.8m to advance new class of antibiotics
Technology could form the basis of a new class of antibiotics
Subscribe now